{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:15:16Z","timestamp":1792419316168,"version":"4.5.0"},"reference-count":51,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070854"],"award-info":[{"award-number":["82070854"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900720"],"award-info":[{"award-number":["81900720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700720"],"award-info":[{"award-number":["81700720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700699"],"award-info":[{"award-number":["81700699"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Observational studies have shown that nonalcoholic fatty liver disease (NAFLD) is highly correlated with serum uric acid (SUA). However, these studies have an inherent risk of bias due to reverse causality. Here, we perform a Mendelian randomization (MR) study to investigate causality between SUA and NAFLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a 2-sample bidirectional MR analysis using summary-level data from genome-wide association studies of SUA (with up to 110 347 individuals) and NAFLD (1483 cases and 17781 controls) in European populations. First, 13 single nucleotide polymorphisms (SNPs) associated with SUA were selected as instruments to estimate the causal effect of elevated SUA levels on the risk of NAFLD using the inverse-variance weighted (IVW) method. Then we performed MR with 3 SNPs as genetic instruments for NAFLD. To test the reliability, further sensitivity analyses were also conducted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our MR analyses demonstrated that NAFLD was associated with SUA levels (\u03b2\u2005=\u20050.032, P = 0.003). Similar results were obtained using other MR methods and in sensitivity analyses. Genetic predisposition to elevated SUA levels was not associated with NAFLD (IVW MR, odds ratio\u2005=\u20051.02, 95% CI: 0.90-1.15, P\u2005=\u20050.775). Similar results were obtained using other 4 pleiotropy robust MR methods and in sensitivity analyses, excluding 9 SNPs associated with potential confounders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our study supports the causal increased SUA levels by NAFLD, while our study does not confirm a causal association for SUA levels on risk of NAFLD. Further study is needed to interpret the potential mechanisms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac190","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:41:21Z","timestamp":1648824081000},"page":"e3497-e3503","source":"Crossref","is-referenced-by-count":36,"title":["Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6521-186X","authenticated-orcid":false,"given":"Shiwei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-2037","authenticated-orcid":false,"given":"Haijun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhuo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2665-4072","authenticated-orcid":false,"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-3622","authenticated-orcid":false,"given":"Jingqiu","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital , Tianjin , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"issue":"1","key":"2022071417224156700_CIT0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"2022071417224156700_CIT0002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol."},{"issue":"1):bnz009","key":"2022071417224156700_CIT0003","article-title":"Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr Rev."},{"issue":"47","key":"2022071417224156700_CIT0004","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol."},{"issue":"2","key":"2022071417224156700_CIT0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2022071417224156700_CIT0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"11","key":"2022071417224156700_CIT0007","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res."},{"issue":"5","key":"2022071417224156700_CIT0008","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome: evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"issue":"10","key":"2022071417224156700_CIT0009","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"2","key":"2022071417224156700_CIT0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/BOR.0b013e32835d951e","article-title":"Metabolic syndrome, diabetes, and hyperuricemia","volume":"25","author":"Li","year":"2013","journal-title":"Curr Opin Rheumatol."},{"issue":"16","key":"2022071417224156700_CIT0011","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/1381612827666210104124320","article-title":"Serum uric acid and diabetes: from pathophysiology to cardiovascular disease","volume":"27","author":"Katsiki","year":"2021","journal-title":"Curr Pharm Des."},{"issue":"5","key":"2022071417224156700_CIT0012","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jare.2016.11.004","article-title":"Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review","volume":"8","author":"Sharaf El Din","year":"2017","journal-title":"J Adv Res."},{"issue":"6","key":"2022071417224156700_CIT0013","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1152\/ajpendo.00518.2020","article-title":"High uric acid induces liver fat accumulation via ROS\/JNK\/AP-1 signaling","volume":"320","author":"Xie","year":"2021","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"2022071417224156700_CIT0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2021.04.005","article-title":"Hepatic accumulation of hypoxanthine: a link between hyperuricemia and nonalcoholic fatty liver disease","author":"Toledo-Ibelles","year":"2021;52(7):692-702","journal-title":"Arch Med Res."},{"issue":"1","key":"2022071417224156700_CIT0015","first-page":"64","article-title":"Association of non-alcoholic fatty liver disease with serum uric acid","volume":"31","author":"Abbasi","year":"2019","journal-title":"J Ayub Med Coll Abbottabad."},{"issue":"5","key":"2022071417224156700_CIT0016","doi-asserted-by":"crossref","first-page":"107874","DOI":"10.1016\/j.jdiacomp.2021.107874","article-title":"Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population","volume":"35","author":"Cui","year":"2021","journal-title":"J Diabetes Complications."},{"issue":"4","key":"2022071417224156700_CIT0017","first-page":"271","article-title":"Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study","volume":"26","author":"Bai","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi."},{"issue":"1","key":"2022071417224156700_CIT0018","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12967-020-02296-x","article-title":"Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study","volume":"18","author":"Ma","year":"2020","journal-title":"J Transl Med."},{"issue":"1","key":"2022071417224156700_CIT0019","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.dsx.2018.10.001","article-title":"Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center","volume":"13","author":"Sandra","year":"2019","journal-title":"Diabetes Metab Syndr."},{"key":"2022071417224156700_CIT0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fendo.2020.00179","article-title":"Higher serum uric acid level predicts non-alcoholic fatty liver disease: a 4-year prospective cohort study","volume":"11","author":"Wei","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"2022071417224156700_CIT0021","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.metabol.2012.08.013","article-title":"Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey","volume":"62","author":"Sirota","year":"2013","journal-title":"Metabolism."},{"issue":"6","key":"2022071417224156700_CIT0022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/liv.13329","article-title":"Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis","volume":"37","author":"Wijarnpreecha","year":"2017","journal-title":"Liver Int."},{"issue":"2","key":"2022071417224156700_CIT0023","first-page":"136","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis","volume":"49","author":"Darmawan","year":"2017","journal-title":"Acta Med Indones."},{"issue":"11","key":"2022071417224156700_CIT0024","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1210\/jc.2015-2527","article-title":"Serum uric acid levels and risk of metabolic syndrome: a dose-response meta-analysis of prospective studies","volume":"100","author":"Yuan","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022071417224156700_CIT0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jped.2012.12.008","article-title":"Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents","volume":"89","author":"Cardoso","year":"2013","journal-title":"J Pediatr (Rio J)."},{"issue":"9","key":"2022071417224156700_CIT0026","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1291\/hypres.30.823","article-title":"Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki","volume":"30","author":"Baba","year":"2007","journal-title":"Hypertens Res."},{"issue":"8","key":"2022071417224156700_CIT0027","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med."},{"issue":"R1","key":"2022071417224156700_CIT0028","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet."},{"issue":"2","key":"2022071417224156700_CIT0029","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"K\u00f6ttgen","year":"2013","journal-title":"Nat Genet."},{"issue":"19","key":"2022071417224156700_CIT0030","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA."},{"issue":"4","key":"2022071417224156700_CIT0031","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in mendelian randomization studies","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep."},{"issue":"3","key":"2022071417224156700_CIT0032","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol."},{"issue":"1","key":"2022071417224156700_CIT0033","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1038\/s41598-021-93105-y","article-title":"Understanding the effect of smoking and drinking behavior on Parkinson\u2019s disease risk: a Mendelian randomization study","volume":"11","author":"Dom\u00ednguez-Bale\u00f3n","year":"2021","journal-title":"Sci Rep."},{"issue":"11","key":"2022071417224156700_CIT0034","doi-asserted-by":"crossref","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med."},{"issue":"7","key":"2022071417224156700_CIT0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol."},{"issue":"5","key":"2022071417224156700_CIT0036","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet."},{"issue":"2","key":"2022071417224156700_CIT0037","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol."},{"issue":"4","key":"2022071417224156700_CIT0038","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol."},{"issue":"6","key":"2022071417224156700_CIT0039","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol."},{"issue":"4","key":"2022071417224156700_CIT0040","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/ije\/dyy080","article-title":"Modal-based estimation via heterogeneity-penalized weighting: model averaging for consistent and efficient estimation in Mendelian randomization when a plurality of candidate instruments are valid","volume":"47","author":"Burgess","year":"2018","journal-title":"Int J Epidemiol."},{"key":"2022071417224156700_CIT0041","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7:e34408","author":"Hemani","year":"2018","journal-title":"Elife."},{"issue":"6","key":"2022071417224156700_CIT0042","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol."},{"issue":"3","key":"2022071417224156700_CIT0043","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ije\/dyu005","article-title":"Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome","volume":"43","author":"Burgess","year":"2014","journal-title":"Int J Epidemiol."},{"key":"2022071417224156700_CIT0044","article-title":"Supplemental data for: Serum uric acid levels and nonalcoholic","author":"Li","journal-title":"Figshare"},{"key":"2022071417224156700_CIT0045","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1038\/srep14325","article-title":"Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence: a meta-analysis of prospective studies","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep."},{"key":"2022071417224156700_CIT0046","doi-asserted-by":"crossref","first-page":"102271","DOI":"10.1016\/j.redox.2022.102271","article-title":"U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia","volume":"51","author":"Crawley","year":"2022","journal-title":"Redox Biol."},{"issue":"2","key":"2022071417224156700_CIT0047","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12072-015-9682-5","article-title":"Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back","volume":"10","author":"Xu","year":"2016","journal-title":"Hepatol Int."},{"issue":"4","key":"2022071417224156700_CIT0048","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","article-title":"Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism","volume":"64","author":"Wan","year":"2016","journal-title":"J Hepatol."},{"issue":"48","key":"2022071417224156700_CIT0049","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J Biol Chem."},{"issue":"2","key":"2022071417224156700_CIT0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/liv.15118","article-title":"Causal effects from non-alcoholic fatty liver disease on kidney function: a Mendelian randomization study","volume":"42","author":"Park","year":"2022","journal-title":"Liver Int."},{"issue":"1","key":"2022071417224156700_CIT0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17117-4","article-title":"Avoiding dynastic, assortative mating, and population stratification biases in Mendelian randomization through within-family analyses","volume":"11","author":"Brumpton","year":"2020","journal-title":"Nat Commun."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac190\/44121517\/dgac190.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/8\/e3497\/44886367\/dgac190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/8\/e3497\/44886367\/dgac190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:26:32Z","timestamp":1657819592000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/8\/e3497\/6562281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,4,1]]},"published-print":{"date-parts":[[2022,7,14]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac190","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,4,1]]}}}